Citing ischemic colitis concerns, FDA denies a petition to allow ANDAs for generic copies of Braintree’s HalfLytely (10 mg bisacodyl) Bowel Prep Kit product.
An appeals court rules in FDA’s favor and affirms a lower court decision that gave deference to the agency when it decided that a supplemental NDA for AstraZeneca’s was not entitled to any additional marketing exclusivity.
Hospira recalls one lot of 0.9% sodium chloride injection, USP, 100 mL, flexible container after confirming a customer complaint involving particulate issues.
Citing federal preemption grounds, an Iowa appeals court affirms several lower court decisions dismissing a failure-to-warn lawsuit by an injured plaintiff taking generic Reglan.